Angewandte Chemie International Edition · 2019 · 63 citations · 27 references
PharmacyBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryProteomicsActivity-based Protein ProfilingChemical Probe DiscoveryMass Spectrometry-based ProteomicsProteomic ProfilingActivity-based Probe DesignCysteine Reactivity ProfilingDrug-target EngagementElectrophile-based ProbesIrreversible ReactionsTarget Engagement AssessmentTarget Engagement Selectivity
Reversible covalency, achieved with, for instance, highly electron-deficient olefins, offers a compelling strategy to design chemical probes and drugs that benefit from the sustained target engagement afforded by irreversible compounds, while avoiding permanent protein modification. Reversible covalency has mainly been evaluated for cysteine residues in individual kinases and the broader potential for this strategy to engage cysteines across the proteome remains unexplored. Herein, we describe a mass-spectrometry-based platform that integrates gel filtration with activity-based protein profiling to assess cysteine residues across the human proteome for both irreversible and reversible interactions with small-molecule electrophiles. Using this method, we identify numerous cysteine residues from diverse protein classes that are reversibly engaged by cyanoacrylamide fragment electrophiles, revealing the broad potential for reversible covalency as a strategy for chemical-probe discovery.
27
Quantitative reactivity profiling predicts functional cysteines in proteomes
Eranthie Weerapana, Chu Wang, Gabriel M. Simon et al. · Nature · 2010 · 1.7K citations · Full text
Lee Honigberg, Ashley M. Smith, Mint Sirisawad et al. · Proceedings of the National Academy of Sciences · 2010 · 1.5K citations · Full text
Proteome-wide covalent ligand discovery in native biological systems
Keriann M. Backus, Bruno E. Correia, Kenneth M. Lum et al. · Nature · 2016 · 978 citations
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd, Bonnie K. Harrington, Susan O’Brien et al. · New England Journal of Medicine · 2015 · 891 citations · Full text
David J. Augeri, Jeffrey A. Robl, David A. Betebenner et al. · Journal of Medicinal Chemistry · 2005 · 621 citations · Full text